Literature DB >> 12130680

Inhibition of branched-chain alpha-keto acid dehydrogenase kinase and Sln1 yeast histidine kinase by the antifungal antibiotic radicicol.

Paul G Besant1, Michael V Lasker, Cuong D Bui, Christoph W Turck.   

Abstract

The 90-kDa heat shock family (HSP90) of protein and two-component histidine kinases, although quite distinct at the primary amino acid sequence level, share a common structural ATP-binding domain known as the Bergerat fold. The Bergerat fold is important for the ATPase activity and associated chaperone function of HSP90. Two-component histidine kinases occur in bacteria, yeast, and plants but have yet to be identified in mammalian cells. The antifungal antibiotic radicicol (Monorden) has been shown to bind to the Bergerat fold of HSP90 and to inhibit its ATPase activity. The structural similarity between the Bergerat fold of HSP90 and bacterial two-component histidine kinases prompted our inquiry into whether radicicol could be a potential inhibitor of histidine kinase-like proteins. Structural homology searches suggest that the ATP-binding domains of the yeast histidine kinase Sln1 and the mammalian, branched-chain alpha-keto acid dehydrogenase kinase are very similar to that of other Bergerat fold family members. On the basis of structural homology, we tested radicicol as a potential inhibitor of Sln1 and branched-chain alpha-keto acid dehydrogenase kinase (BCKDHK) and propose a mechanism of inhibition of these kinases. Although BCKDHK has been shown to have serine autophosphorylation activity, we speculate, based on the results from this study and other supporting evidence, that BCKDHK may also have intrinsic histidine kinase activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130680     DOI: 10.1124/mol.62.2.289

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  New class of competitive inhibitor of bacterial histidine kinases.

Authors:  Raymond Gilmour; J Estelle Foster; Qin Sheng; Jonathan R McClain; Anna Riley; Pei-Ming Sun; Wai-Leung Ng; Dalai Yan; Thalia I Nicas; Kenneth Henry; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

2.  A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases.

Authors:  Michael T Guarnieri; Brian S J Blagg; Rui Zhao
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

Review 3.  Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development.

Authors:  Len Neckers; Brian Blagg; Timothy Haystead; Jane B Trepel; Luke Whitesell; Didier Picard
Journal:  Cell Stress Chaperones       Date:  2018-02-01       Impact factor: 3.667

4.  Probing Mechanistic Similarities between Response Regulator Signaling Proteins and Haloacid Dehalogenase Phosphatases.

Authors:  Robert M Immormino; Chrystal A Starbird; Ruth E Silversmith; Robert B Bourret
Journal:  Biochemistry       Date:  2015-05-28       Impact factor: 3.162

5.  An RNA aptamer specific to Hsp70-ATP conformation inhibits its ATPase activity independent of Hsp40.

Authors:  Deepak Thirunavukarasu; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2015-02-05       Impact factor: 5.486

6.  Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.

Authors:  Masato Kato; Jun Li; Jacinta L Chuang; David T Chuang
Journal:  Structure       Date:  2007-08-02       Impact factor: 5.006

7.  Detection of changes in gene regulatory patterns, elicited by perturbations of the Hsp90 molecular chaperone complex, by visualizing multiple experiments with an animation.

Authors:  Pablo C Echeverría; Fedor Forafonov; Deo P Pandey; Guillaume Mühlebach; Didier Picard
Journal:  BioData Min       Date:  2011-06-14       Impact factor: 2.522

8.  Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol.

Authors:  D Gadelle; C Bocs; M Graille; P Forterre
Journal:  Nucleic Acids Res       Date:  2005-04-22       Impact factor: 16.971

9.  Analysis of HSP90-related folds with MED-SuMo classification approach.

Authors:  Olivia Doppelt-Azeroual; Fabrice Moriaud; François Delfaud; Alexandre G de Brevern
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

10.  Evolution of kinase polypharmacology across HSP90 drug discovery.

Authors:  Albert A Antolin; Paul A Clarke; Ian Collins; Paul Workman; Bissan Al-Lazikani
Journal:  Cell Chem Biol       Date:  2021-06-01       Impact factor: 8.116

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.